We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$456M
AUM Growth
-$51.4M
Cap. Flow
-$67.4M
Cap. Flow %
-14.77%
Top 10 Hldgs %
90.19%
Holding
20
New
1
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
IOT icon
Samsara
IOT
+$5.96M
2
FIG
Figma
FIG
+$1.26M

Top Sells

Rank Stock Value
1
DASH icon
DoorDash
DASH
+$73M
2
CPNG icon
Coupang
CPNG
+$1.63M

Sector Composition

Rank Sector Weight
1 Technology 36.87%
2 Healthcare 26.98%
3 Financials 25.17%
4 Consumer Discretionary 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NU icon
1
Nu Holdings
NU
$59.7B
$115M 25.17%
7,175,434
– –
KVYO icon
2
Klaviyo
KVYO
$4.34B
$97.3M 21.33%
3,515,065
– –
BBNX
3
Beta Bionics
BBNX
$1.05B
$70.9M 15.54%
3,570,113
– –
CPNG icon
4
Coupang
CPNG
$24.9B
$25.6M 5.61%
795,006
-54,025
-6% -$1.63M
DASH icon
5
DoorDash
DASH
$81.1B
$24.5M 5.37%
90,142
-291,060
-76% -$73M
IOT icon
6
Samsara
IOT
$22.2B
$22.3M 4.89%
598,914
+160,429
+37% +$5.96M
IKT icon
7
Inhibikase Therapeutics
IKT
$282M
$17.7M 3.89%
10,950,000
– –
DDOG icon
8
Datadog
DDOG
$96.4B
$16.9M 3.7%
118,707
– –
MNDY icon
9
monday.com
MNDY
$3.21B
$11.3M 2.48%
58,336
– –
TARS icon
10
Tarsus Pharmaceuticals
TARS
$3.59B
$10.1M 2.21%
170,000
– –
CRWD icon
11
CrowdStrike
CRWD
$269B
$7.66M 1.68%
62,460
– –
SNOW icon
12
Snowflake
SNOW
$117B
$6.09M 1.33%
27,005
– –
ABOS icon
13
Acumen Pharmaceuticals
ABOS
$163M
$5.84M 1.28%
3,417,075
– –
TOST icon
14
Toast
TOST
$17.6B
$5.72M 1.25%
156,604
– –
TXG icon
15
10x Genomics
TXG
$11.7B
$5.63M 1.23%
481,770
– –
BIOA
16
BioAge Labs
BIOA
$328M
$4.62M 1.01%
786,353
– –
ACRV icon
17
Acrivon Therapeutics
ACRV
$89.1M
$3.84M 0.84%
2,122,605
– –
TSHA icon
18
Taysha Gene Therapies
TSHA
$1.63B
$2.37M 0.52%
724,873
– –
CADL icon
19
Candel Therapeutics
CADL
$833M
$2.07M 0.45%
405,837
– –
FIG
20
Figma
FIG
$11B
$948K 0.21%
+18,286
New +$1.26M

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q3 2025 Portfolio in Review

As of Q3 2025, Sands Capital Ventures held 20 positions worth $456M, down 10% from $508M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Sands Capital Ventures withdrew a net $67.4M in Q3 2025, reducing 2 holdings. Its largest reduction was DoorDash, cutting an estimated $73M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Sands Capital Ventures opened a new position in Figma worth $948K.

  • Sands Capital Ventures's largest Q3 2025 buy was Figma: 18,286 shares worth $948K.
  • Sands Capital Ventures added most to Samsara in Q3 2025, an estimated $5.96M increase.
  • Sands Capital Ventures's biggest Q3 2025 reduction was DoorDash, cutting an estimated $73M.
  • Sands Capital Ventures's ten largest holdings make up 90% of its $456M portfolio in Q3 2025.
  • Sands Capital Ventures opened 1 new position and closed 0 in Q3 2025.
  • Sands Capital Ventures's portfolio value fell 10% quarter-over-quarter to $456M.

Based on Sands Capital Ventures's 13F filing for Q3 2025, filed 13 Nov 2025.